Incorporating Information from Completed Trials in Future Trial Planning

Drug development is a continuum. Information from completed trials and other sources may be available when we design a new trial. In this chapter we consider the Bayesian approach to incorporate existing information into future trial planning. Under the Bayesian approach, prior distributions are used to describe the accumulated knowledge about unknown parameters such as those representing treatment effects. The prior distributions are then used to calculate the probability of a successful trial or assurance probability. In this chapter, we look at closed-form expressions for assurance probabilities under some definitions of success. We can use simulations to estimate these probabilities when close-form expressions do not exist. With the use of prior distributions for the parameters of interest, we show how to assess the positive and negative predictive values of a design with its companion decision rule.

[1]  Kerrie Mengersen,et al.  Elicitation by design in ecology: using expert opinion to inform priors for Bayesian statistical models. , 2009, Ecology.

[2]  W Ewy,et al.  Model‐based Drug Development , 2007, Clinical pharmacology and therapeutics.

[3]  D. Spiegelhalter,et al.  Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation , 2004 .

[4]  Anthony O'Hagan,et al.  Robust meta‐analytic‐predictive priors in clinical trials with historical control information , 2014, Biometrics.

[5]  Anthony O'Hagan,et al.  Assurance in clinical trial design , 2005 .

[6]  M. Kynn The ‘heuristics and biases’ bias in expert elicitation , 2007 .

[7]  Bradley P Carlin,et al.  Practical Bayesian Design and Analysis for Drug and Device Clinical Trials , 2007, Journal of biopharmaceutical statistics.

[8]  J Cornfield,et al.  The Bayesian outlook and its application. , 1969, Biometrics.

[9]  Modeling and Simulation to Support Dose Selection and Clinical Development of SC‐75416, a Selective COX‐2 Inhibitor for the Treatment of Acute and Chronic Pain , 2008, Clinical pharmacology and therapeutics.

[10]  Simon Day,et al.  Structured approach to the elicitation of expert beliefs for a Bayesian‐designed clinical trial: a case study , 2013, Pharmaceutical statistics.

[11]  Jeremy E. Oakley,et al.  Uncertain Judgements: Eliciting Experts' Probabilities , 2006 .

[12]  David J. Lunn,et al.  The BUGS Book: A Practical Introduction to Bayesian Analysis , 2013 .

[13]  N Benson,et al.  Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development , 2013, Clinical pharmacology and therapeutics.

[14]  Phil Woodward,et al.  Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study , 2015, Pharmaceutical statistics.